The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

After hearing she had two months to live, Middlesex Township resident Wanda Stouffer learned she'd qualified for a treatment ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Confused about hair transplant vs hair restoration? Learn the key differences, benefits, and which option might be right for ...

Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

This study provides valuable findings regarding potential correlates of protection against the African swine fever virus. The evidence supporting the claims is solid, although analysis using a higher ...

A blood test that can be administered in the first trimester of pregnancy identified women at risk for developing preeclampsia 5 months before symptom onset, data show. Researchers said the test — a ...

In a paper published in Science Bulletin, the research team led by Professor Wen Zhang from the Department of Rheumatology and Immunology at Peking Union Medical College Hospital (PUMCH) has made ...

An experimental AstraZeneca (NASDAQ:AZN) drug, anselamimab, failed to extend survival or cut heart-related hospitalizations in patients with a rare plasma cell disorder, disappointing hopes it could ...

AstraZeneca's experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of a rare ...

A new blood test, a liquid biopsy of maternal plasma cell-free RNA (cfRNA) developed by iPremom, can predict pre-eclampsia up to five months before symptom onset, according to a study.The test, which ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...